Clinical Trial Update: A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial in kidney transplant patients completed, investigating optimal immune suppression to prevent kidney rejection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED